Saltar al contenido
Merck

Putative tumor suppression function of SIRT6 in endometrial cancer.

FEBS letters (2015-07-18)
Tomohiko Fukuda, Osamu Wada-Hiraike, Katsutoshi Oda, Michihiro Tanikawa, Chinami Makii, Kanako Inaba, Aki Miyasaka, Yuichiro Miyamoto, Tetsu Yano, Daichi Maeda, Takeshi Sasaki, Kei Kawana, Masashi Fukayama, Yutaka Osuga, Tomoyuki Fujii
RESUMEN

SIRT6, a member of the sirtuin family, has been identified as a candidate tumor suppressor. To pursue the role of SIRT6 in endometrial cancer, we investigated the anti-tumorigenic function of SIRT6. The expression of SIRT6 negatively affected the proliferation of AN3CA and KLE endometrial cancer cells. Increased expression of SIRT6 resulted in the induction of apoptosis by repressing the expression of the anti-apoptotic protein survivin. Consistent with this result, a survivin inhibitor YM155 efficiently inhibited cellular proliferation and induced apoptosis. These results revealed that SIRT6 might function as a tumor suppressor of endometrial cancer cells.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Fluorescein 5(6)-isothiocyanate, BioReagent, suitable for fluorescence, mixture of 2 components, ≥90% (HPLC)
Sigma-Aldrich
Fluorescein 5(6)-isothiocyanate, ≥90% (HPLC)
Sigma-Aldrich
Fluorescein isothiocyanate isomer I, ≥97.5% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Sirt6
Sigma-Aldrich
MISSION® esiRNA, targeting human SIRT6